ISSN: 1308-5727 | E-ISSN: 1308-5735
Volume : Issue : Year : 2023
Forms

Abstracting & Indexing
Turkish Society for Pediatric Endocrinology and Diabetes
Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism [J Clin Res Pediatr Endocrinol]
J Clin Res Pediatr Endocrinol. 2021; 13(3): 263-268 | DOI: 10.4274/jcrpe.galenos.2020.2020.0184

Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism

Melissa Kaori S. Litao1, Ana Gutierrez Alvarez1, Bina Shah1
New York University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, New York, USA

Objective: Neutropenia can occur in untreated autoimmune hyperthyroidism (AIH) or in association with treatment with the anti-thyroid drug, methimazole (MMI). Starting MMI in children and adolescents with AIH and pre-existing neutropenia could thus be worrisome. The aim was to describe the prevalence of neutropenia in pediatric AIH, prior to antithyroid drug therapy and to assess the effect of antithyroid drugs on neutrophil count.
Methods: Patients with AIH attending a pediatric endocrinology clinic were retrospectively reviewed. Absolute neutrophil count (ANC) data at presentation and during anti-thyroid treatment for up to 24 weeks was collected. AIH was defined as elevated free thyroxine (fT4) or free tri-iodothyronine (fT3), suppressed thyroid stimulating hormone, and positive thyroid autoantibodies. Neutropenia was defined as ANC <1500 cells/L.
Results: Thirty-one patients (71% female) were included with a median interquartile range (IQR) age of 14.71 (11.89-17.10) years. Neither fT4 nor fT3 levels correlated with ANC at presentation (rs=0.22, p=0.24 and rs=0.13, p=0.54, respectively). 26/31 (84%) had normal baseline ANC. None developed neutropenia with thionamides. 5/31 (16%) had baseline neutropenia (median ANC 1,200/L; IQR 874-1200). Four of these five started MMI at diagnosis while one was started on propranolol only but MMI was started one week later. All five normalized ANC within 24 weeks.
Conclusion: In this cohort, 16% of AIH patients had neutropenia at presentation, but this resolved in the short term and did not worsen with thionamides. Thionamides may be used with caution in these patients with close monitoring of blood counts.

Keywords: Hyperthyroidism, neutropenia, thionamides, methimazole, agranulocytosis

Melissa Kaori S. Litao, Ana Gutierrez Alvarez, Bina Shah. Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism. J Clin Res Pediatr Endocrinol. 2021; 13(3): 263-268
Manuscript Language: English
LookUs & Online Makale